Ernexa Therapeutics Inc. (ERNA) › RevenueErnexa Therapeutics Inc. (ERNA) — RevenueAnnual figures by fiscal year, from SEC filings.2013: $23.75M2014: $26.05M2015: $24.52M2016: $22.31M2017: $21.27M2018: $23.34M2019: $19.81M2020: $5.80M2022: $02023: $68.0K2024: $582.0K$582.0K2013Revenue (USD)2024Fiscal YearRevenueChange YoY2024$582.0K+755.9%2023$68.0K—2022$0—2020$5.80M-70.7%2019$19.81M-15.1%2018$23.34M+9.7%2017$21.27M-4.7%2016$22.31M-9.0%2015$24.52M-5.9%2014$26.05M+9.7%2013$23.75M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share